Abstract |
No effective treatment has been demonstrated for patients with acute transverse myelopathy. In a multicentre controlled study, 12 children with severe acute transverse myelopathy were treated with intravenous methylprednisolone (IVMP) and compared with a historical group of 17 patients. The treatment had a significant effect on the proportion of patients walking independently at 1 month and on the proportion with full recovery at 1 year, with no differences in the frequency of complications between the two groups.
|
Authors | P Defresne, L Meyer, M Tardieu, E Scalais, C Nuttin, B De Bont, G Loftus, P Landrieu, H Kadhim, G Sébire |
Journal | Journal of neurology, neurosurgery, and psychiatry
(J Neurol Neurosurg Psychiatry)
Vol. 71
Issue 2
Pg. 272-4
(Aug 2001)
ISSN: 0022-3050 [Print] England |
PMID | 11459911
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adolescent
- Child
- Child, Preschool
- Dose-Response Relationship, Drug
- Female
- Humans
- Infant
- Male
- Methylprednisolone
(administration & dosage, adverse effects)
- Myelitis, Transverse
(drug therapy)
|